my cart
log-in
Search for:
Search for:
applications / products
Applications
Drug Discovery & Development
Potency & QC Lot Release
Detect Neutralizing Abs
Cytotoxicity Assays
Target Engagement
Translocation Assays
Pharmacotrafficking Assays
Do-It-Yourself Assays
Therapeutic/Disease Area
Custom Assay Development
Products
Cells & Cell Lines
Assay Ready Kits
Bioassay Kits
eXpress Kits
Frozen Cells
Membrane Preps
Proteins & Kinases
Cell Culture Reagents
Detection Reagents
Biochemical Assays
Control Ligands & Inhibitors
targets
A-Z List of Targets
GPCRs
Kinases
Checkpoint Receptors
Ion Channels
Cytokines & Interleukins
Signaling Pathways
Nuclear Proteins
Epigenetics Proteins
technologies / platforms
Enzyme Fragment Complementation
Human Primary Cell Screening
Competition Binding Platform
tools / resources
Document Resource Library
Flyers & Brochure
User Manuals & Protocols
White Papers & Applications
Scientific Posters
Presentations
Webinars
Blogs
Publications & References
CRO Certification
Reagent Calculators
Instrument Compatibility
services
Contact Us
Customer & Technical Support
Submit an Order
Technical Resources
Literature & Email Signup
Legal & Policies
Locations
Distributors
about us
Company
Contact Us
Careers
Announcements
Events
About Us
/
Announcements
Contact a Specialist
About Us
Careers
Announcements
Events
News & Press Releases
9/12/2013
DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research
11/7/2012
Discoverx Corporation Acquires BioSeek® - Adds Primary Cell Assays to Portfolio of Drug Discovery Solutions
6/5/2012
DiscoveRx Breaks the Barriers of Conventional Cell-Based Screening With Launch of a Powerful New InCELL Hunter™ Platform
5/16/2012
DiscoveRx Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic "Reader" Proteins
5/1/2012
Comprehensive PathHunter® Assay Portfolio Driving Antibody Therapeutic Discovery Programs
2/3/2012
DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs
11/29/2011
Compugen and DiscoveRx® Form Collaboration to Commercialize Novel Peptide Ligands for GPCR Drug Targets
11/16/2011
DiscoveRx® Corporation's KINOMEscan® technology reveals kinome-wide fingerprints against diverse set of mature kinase inhibitors and FDA approved therapeutics
9/6/2011
An Unprecedented Industry-Academia Alliance to Accelerate GPCR Deorphanization Efforts
6/2/2011
DiscoveRx Corporation Announces the Expansion of KINOMEscan's Largest Commercial Available Kinase Panel
Displaying results 21-30 (of 42)
|<
<
1
-
2
-
3
-
4
-
5
>
>|